Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 1,093,289 | 1,036,484 | 1,068,913 | 1,092,964 | 993,444 |
| Cost of Goods | 90,721 | 98,197 | 101,161 | 107,493 | 92,401 |
| Gross Profit | 1,002,568 | 938,287 | 967,752 | 985,471 | 901,043 |
| Operating Expenses | 780,375 | 633,526 | 642,953 | 640,114 | 604,647 |
| Operating Income | 222,914 | 304,958 | 324,960 | 345,850 | 296,797 |
| Other Income | 14,680 | 6,846 | -33,077 | -23,713 | -4,018 |
| Pre-tax Income | 237,594 | 311,804 | 291,883 | 322,137 | 292,779 |
| Income Tax | 92,709 | 65,225 | 83,456 | 114,337 | 84,706 |
| Net Income Continuous | 144,885 | 246,579 | 208,427 | 207,800 | 208,073 |
| Minority Interests | 2,040 | 2,592 | 1,773 | 1,012 | 1,445 |
| Net Income | $142,845 | $243,987 | $206,654 | $206,788 | $206,628 |
| EPS Basic Total Ops | 0.49 | 0.85 | 0.70 | 0.71 | 0.71 |
| EPS Basic Continuous Ops | 0.50 | 0.86 | 0.71 | 0.71 | 0.72 |
| EPS Diluted Total Ops | 0.49 | 0.84 | 0.71 | 0.70 | 0.70 |
| EPS Diluted Continuous Ops | 0.50 | 0.85 | 0.71 | 0.71 | 0.71 |
| EBITDA(a) | $349,645 | $427,104 | $446,977 | $473,421 | $402,336 |